Sustained release preparations are exported to Australia and multiple ANDA products are approved in the United States.
2015
Acquisition of the Polygen pharmaceutical plant in the United States;
2014
The solid preparation workshop is certified by the US FDA;
2009
Approved by the SAIC, it was successfully declared as a national enterprise.
2007
The medical bones and ichthyosis tablets of Merro Chinese Medicine Factory were awarded the national patent certificate.
2005
In 2005, it obtained TGA international certification, and in the same year, it exported to New Zealand, which is the first batch of preparation export enterprises in China;
2000
The first batch of national GMP certification;
1989
Established China Pfizer Pharmaceutical Co., Ltd., a joint venture with Pfizer Pharmaceuticals of the United States, and is the first large-scale joint venture in China;
1957
It is the first to develop erythromycin in China and become the earliest antibiotic production base in New China;
1925
Merro Pharmaceutical was founded in 1925 by the Dalian Manchurian Health Research Institute;